Journal for ImmunoTherapy of Cancer Issues Research Articles in May 2023 Edition
June 02, 2023
June 02, 2023
MILWAUKEE, Wisconsin, June 2 -- The Journal for ImmunoTherapy of Cancer, a peer-reviewed journal from the Society for Immunotherapy of Cancer that says it features all aspects of tumor immunology and cancer immunotherapy, published research articles on the following topics in its May 2023 edition:
Basic tumor immunology:
* Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA mole . . .
Basic tumor immunology:
* Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA mole . . .